In the current market session, Starbucks Inc. (NASDAQ:SBUX) share price is at $86.83, after a 1.70% decrease. Over the past month, the stock went up by 1.07%, but over the past year, it actually decreased by 3.43%. With good short-term…
For U.S. mining investors, shifts in federal policy — particularly during the Donald Trump administration — have reshaped how capital evaluates large domestic projects. In an exclusive email interview with Benzinga, John Shively, CEO of Pebble Limited Partnership, said executive…
When investors think about insurance, they usually think about bonds or cash — not barrels, tons, or ounces. For Goldman Sachs, it’s commodities. As supply chains grow more concentrated, U.S.–China competition intensifies, and geopolitical conflicts increasingly spill into trade and…
In the current session, the stock is trading at $216.69, after a 0.67% spike. Over the past month, Dave Inc. (NASDAQ:DAVE) stock increased by 3.38%, and in the past year, by 124.85%. With performance like this, long-term shareholders are optimistic…
Strategy Inc. (NASDAQ:MSTR) sold $747.8 million in stock but bought zero Bitcoin (CRYPTO: BTC) the prior week, breaking its accumulation streak as the stock hovers just above critical $155 support. No BTC Buys, Just Equity Sales Strategy reported no new…
China's dominance in mineral processing — not mining — is emerging as the defining fault line in the global race for critical resources such as copper. The U.S. imports roughly 60% of the copper it consumes — a reliance drawing…
Gilead Sciences, Inc. (NASDAQ:GILD) and Assembly Biosciences, Inc. (NASDAQ:ASMB) announced on Monday that Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus (HSV) helicase-primase inhibitor programs, including long-acting investigational candidates ABI-1179 and ABI-5366 for recurrent…
Carnival Corporation (NYSE:CCL) stock rose Monday after the cruise operator reported record fourth-quarter profit and cash flow. Following the results, Goldman Sachs analyst Lizzie Dove raised her price forecast to $34 from $31 and reiterated a Buy rating. Earnings Snapshot…
In the current market session, Amdocs Inc. (NASDAQ:DOX) share price is at $80.35, after a 0.16% decrease. Over the past month, the stock increased by 5.43%, but over the past year, it actually decreased by 7.26%. With good short-term performance…
Immutep Limited (NASDAQ:IMMP) on Monday shared an update from the placebo-controlled, double-blind first-in-human Phase I study in healthy participants evaluating IMP761, a first-in-class LAG-3 agonist antibody for autoimmune diseases. The single-ascending dose escalation portion of the trial completed the 2.5…